VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,930,000 | +604.4% | 80,000 | +700.0% | 0.53% | +580.8% |
| Q2 2022 | $274,000 | -76.2% | 10,000 | -66.7% | 0.08% | -76.9% |
| Q1 2022 | $1,151,000 | +71.0% | 30,000 | +42.9% | 0.34% | +41.6% |
| Q4 2021 | $673,000 | -88.7% | 21,000 | -89.6% | 0.24% | -76.4% |
| Q3 2021 | $5,932,000 | -39.7% | 201,300 | -30.4% | 1.01% | +61.9% |
| Q2 2021 | $9,830,000 | +184.3% | 289,300 | +171.9% | 0.62% | -45.3% |
| Q1 2021 | $3,458,000 | +296.1% | 106,400 | +661.3% | 1.14% | +12.2% |
| Q4 2020 | $873,000 | -97.9% | 13,977 | -98.7% | 1.02% | -80.0% |
| Q3 2020 | $41,237,000 | +181.1% | 1,053,000 | +163.2% | 5.09% | +99.7% |
| Q2 2020 | $14,672,000 | – | 400,000 | – | 2.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |